Your browser doesn't support javascript.
loading
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
Crane, Christopher H; Eng, Cathy; Feig, Barry W; Das, Prajnan; Skibber, John M; Chang, George J; Wolff, Robert A; Krishnan, Sunil; Hamilton, Stanley; Janjan, Nora A; Maru, Dipen M; Ellis, Lee M; Rodriguez-Bigas, Miguel A.
Affiliation
  • Crane CH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ccrane@mdanderson.org
Int J Radiat Oncol Biol Phys ; 76(3): 824-30, 2010 Mar 01.
Article in En | MEDLINE | ID: mdl-19464823

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2010 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2010 Document type: Article Affiliation country: United States